These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 25443457)
21. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes]. Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436 [TBL] [Abstract][Full Text] [Related]
22. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y; Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576 [TBL] [Abstract][Full Text] [Related]
23. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49). Günther JH; Frambach M; Deinert I; Brandau S; Jocham D; Böhle A J Urol; 1999 May; 161(5):1702-6. PubMed ID: 10210443 [TBL] [Abstract][Full Text] [Related]
24. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer. Miyazaki J; Hinotsu S; Ishizuka N; Naito S; Ozono S; Akaza H; Nishiyama H Jpn J Clin Oncol; 2013 Aug; 43(8):827-34. PubMed ID: 23858038 [TBL] [Abstract][Full Text] [Related]
25. Combination of sensitizing pretreatment and radiofrequency tumor ablation: evaluation in rat model. Weinberg BD; Krupka TM; Haaga JR; Exner AA Radiology; 2008 Mar; 246(3):796-803. PubMed ID: 18309015 [TBL] [Abstract][Full Text] [Related]
26. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. Wong SN; Lin CJ; Lin CC; Chen WT; Cua IH; Lin SM AJR Am J Roentgenol; 2008 Mar; 190(3):W187-95. PubMed ID: 18287411 [TBL] [Abstract][Full Text] [Related]
27. Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model. Kroeze SG; Daenen LG; Nijkamp MW; Roodhart JM; de Gast GC; Bosch JL; Jans JJ J Urol; 2012 Aug; 188(2):607-14. PubMed ID: 22704448 [TBL] [Abstract][Full Text] [Related]
28. Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors. Yan F; Wang S; Yang W; Goldberg SN; Wu H; Duan WL; Deng ZT; Han HB; Zheng HR Radiology; 2017 Nov; 285(2):462-471. PubMed ID: 28631963 [TBL] [Abstract][Full Text] [Related]
29. Injectable polymer depot combined with radiofrequency ablation for treatment of experimental carcinoma in rat. Krupka TM; Weinberg BD; Ziats NP; Haaga JR; Exner AA Invest Radiol; 2006 Dec; 41(12):890-7. PubMed ID: 17099428 [TBL] [Abstract][Full Text] [Related]
31. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Hines-Peralta A; Sukhatme V; Regan M; Signoretti S; Liu ZJ; Goldberg SN Radiology; 2006 Jul; 240(1):82-9. PubMed ID: 16720872 [TBL] [Abstract][Full Text] [Related]
32. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175 [TBL] [Abstract][Full Text] [Related]
33. RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model. Solazzo S; Mertyna P; Peddi H; Ahmed M; Horkan C; Goldberg SN Int J Hyperthermia; 2008 Nov; 24(7):560-7. PubMed ID: 18608584 [TBL] [Abstract][Full Text] [Related]
34. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy. Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571 [TBL] [Abstract][Full Text] [Related]
35. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258 [TBL] [Abstract][Full Text] [Related]
36. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480 [TBL] [Abstract][Full Text] [Related]
37. Vaccination of cattle with Mycobacterium bovis BCG by a combination of systemic and oral routes. Buddle BM; Denis M; Aldwell FE; Martin Vordermeier H; Glyn Hewinson R; Neil Wedlock D Tuberculosis (Edinb); 2008 Nov; 88(6):595-600. PubMed ID: 18439875 [TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Zhang YJ; Liang HH; Chen MS; Guo RP; Li JQ; Zheng Y; Zhang YQ; Lau WY Radiology; 2007 Aug; 244(2):599-607. PubMed ID: 17641378 [TBL] [Abstract][Full Text] [Related]
39. Optimal treatment of systemic bacillus Calmette-Guérin infection: investigations in an animal model. Durek C; Jurczok A; Werner H; Jocham D; Bohle A J Urol; 2002 Aug; 168(2):826-31. PubMed ID: 12131375 [TBL] [Abstract][Full Text] [Related]
40. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group. Agarwala SS; Neuberg D; Park Y; Kirkwood JM Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]